The study of mechanism of miR-34c-5p targeting FLOT2 to regulate proliferation, migration and invasion of osteosarcoma cells

References

• Li S, Sun W, Wang H, et al. Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal. Tumour Biol. 2015;36:1329–1338.
   PubMed Web of Science ®Google Scholar
• Liang W, Gao B, Fu P, et al. The miRNAs in the pathgenesis of osteosarcoma. Front Biosci. 2013;18:788–794.
   Google Scholar
• Wu Y, Ni Z, Yan X, et al. Targeting the MIR34C-5p-ATG4B-autophagy axis enhances the sensitivity of cervical cancer cells to pirarubicin. Autophagy. 2016;12:1105–1117.
   PubMed Web of Science ®Google Scholar
• Wu H, Huang M, Lu M, et al. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Cancer Chemother Pharmacol. 2013;71:1159–1171.
   PubMed Web of Science ®Google Scholar
• Gu J, Wang G, Liu H, et al. SATB2 targeted by methylated miR-34c-5p suppresses proliferation and metastasis attenuating the epithelial-mesenchymal transition in colorectal cancer. Cell Prolif. 2018;51:e12455.
   PubMed Web of Science ®Google Scholar
• Procopio M, Re M, Magliulo G, et al. Expression levels and clinical significance of miR-21-5p, miR-let-7a, and miR-34c-5p in laryngeal squamous cell carcinoma. BioMed Res Int. 2017;2017:3921258.
   PubMed Web of Science ®Google Scholar
• Amaral AJ, Andrade J, Foxall RB, et al. miRNA profiling of human naive CD4 T cells links miR-34c-5p to cell activation and HIV replication. EMBO J. 2017;36:346–360.
   PubMed Web of Science ®Google Scholar
• López JA, Alvarezsalas LM. Differential effects of miR-34c-3p and miR-34c-5p on SiHa cells proliferation apoptosis, migration and invasion. Biochem Biophys Res Commun. 2011;409:513–519.
   PubMed Web of Science ®Google Scholar
• Feifei MA, Hao Y, Wang G, et al. The effect of up-regulating miR-34c-5p on the proliferation and invasion of nasopharyngeal carcinoma cell line HONE-1. Tianjin Med J. 2015;21(23):5378–5385.
   Google Scholar
• Fei W, Wang HB. Research progress of the relationship between Flot2 and malignant tumor. J Modern Oncol. 2017;25:816–819.
   Google Scholar
• Jones KB, Salah Z, Del MS, et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res. 2012;72:1865–1877.
   PubMed Web of Science ®Google Scholar
• Kobayashi E, Hornicek FJ, Duan Z. MicroRNA involvement in osteosarcoma. Sarcoma. 2012;2012:359739.
   PubMedGoogle Scholar
• Pu Y, Zhao F, Li Y, et al. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene. BMC Cancer. 2017;17:45.
   PubMed Web of Science ®Google Scholar
• Zhao F, Pu Y, Cui M, et al. MiR-20a-5p represses the multi-drug resistance of osteosarcoma by targeting the SDC2 gene. Cancer Cell Int. 2017;17:100.
   PubMed Web of Science ®Google Scholar
• Wen J, Zhao YK, Liu Y, et al. MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2. Tumour Biol. 2017;39:1010428317705761.
   Google Scholar
• Zou Y, Huang Y, Yang J, et al. miR-34a is downregulated in human osteosarcoma stem-like cells and promotes invasion, tumorigenic ability and self-renewal capacity. Mol Med Rep. 2017;15:1631–1637.
   PubMed Web of Science ®Google Scholar
• Jin J, Cai L, Liu ZM, et al. miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev. 2013;14:3681–3684.
   PubMedGoogle Scholar
• Tao J, Cong H, Wang H, et al. MiR-30a-5p inhibits osteosarcoma cell proliferation and migration by targeting FOXD1. Biochem Biophys Res Commun. 2018;503:1092–1097.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yang C, Wang K, et al. MicroRNA-33b inhibits the proliferation and migration of osteosarcoma cells via targeting hypoxia-inducible factor-1α. Oncol Res. 2017;25:397–405.
   PubMed Web of Science ®Google Scholar
• Xie Y, Sun W, Xiao L, et al. Effect of MiR-99a inhibitor on the biological behavior of human osteosarcoma cells. Med J Wuhan Univ. 2018;39:36–41.
   Google Scholar
• Li C, Xu B, Miu X, et al. Inhibition of miRNA-21 attenuates the proliferation and metastasis of human osteosarcoma by upregulating PTEN. Exp Ther Med. 2018;15:1036–1040.
   PubMed Web of Science ®Google Scholar
• Li N, Mao D, Cao Y, et al. Downregulation of SIRT6 by miR-34c-5p is associated with poor prognosis and promotes colon cancer proliferation through inhibiting apoptosis via the JAK2/STAT3 signaling pathway. Int J Oncol. 2018;52(5):1515–1527.
   PubMed Web of Science ®Google Scholar
• Xu Z, Huang B, Zhang Q, et al. NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p. J Cell Biochem. 2019;120:6596–6604.
   PubMed Web of Science ®Google Scholar
• Peng D, Wang H, Li L, et al. miR-34c-5p promotes eradication of acute myeloid leukemia stem cells by inducing senescence through selective RAB27B targeting to inhibit exosome shedding. Leukemia. 2018;32:1180–1188.
   PubMed Web of Science ®Google Scholar
• Cao K, Xie D, Cao P, et al. SiRNA-mediated flotillin-2 (Flot2) downregulation inhibits cell proliferation, migration, and invasion in gastric carcinoma cells. Oncol Res. 2014;21:271–279.
   PubMed Web of Science ®Google Scholar
• Li Q, Peng J, Li X, et al. miR-449a targets Flot2 and inhibits gastric cancer invasion by inhibiting TGF-β-mediated EMT. Diagn Pathol. 2015;10:202.
   PubMed Web of Science ®Google Scholar
• Wen Q, Alnemah MM, Luo J, et al. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma. Int J Clin Exp Pathol. 2015;8:8236–8243.
   PubMed Web of Science ®Google Scholar
• Zhao L, Lin L, Pan C, et al. Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β. Oncotarget. 2015;6:9781–9793.
   PubMedGoogle Scholar
• Wen Q, Wang W, Chu S, et al. Flot-2 expression correlates with EGFR levels and poor prognosis in surgically resected non-small cell lung cancer. PLoS One. 2015;10:e0132190.
   PubMed Web of Science ®Google Scholar
• Yan Y, Yang FQ, Zhang HM, et al. Up-regulation of flotillin-2 is associated with renal cell carcinoma progression. Tumour Biol. 2014;35:10479–10486.
   PubMedGoogle Scholar
• Wang CH, Zhu XD, Ma DN, et al. Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma. Am J Cancer Res. 2017;7:1068–1083.
   PubMed Web of Science ®Google Scholar
• Li L, Peng X, Wang Y, et al. High expression of Flot-2 promotes the development and invasion of esophageal squamous cell carcinoma. Chinese J Histochem Cytochem. 2017;2:66–70.
   Google Scholar
• Wei G, Xu Y, Peng T, et al. miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2. Artif Cells Nanomed Biotechnol. 2018;46:224–230.
   PubMed Web of Science ®Google Scholar
• Mou X, Liu S. MiR-485 inhibits metastasis and EMT of lung adenocarcinoma by targeting Flot2. Biochem Biophys Res Commun. 2016;477:521–526.
   PubMed Web of Science ®Google Scholar
• Liu R, Xie H, Luo C, et al. Identification of FLOT2 as a novel target for microRNA-34a in melanoma. J Cancer Res Clin Oncol. 2015;141:993–1006.
   PubMed Web of Science ®Google Scholar